Treatment of type 2 diabetes in children: what are the specific considerations?
Expert Opin Pharmacother · 2021
Last updated 2026-05-28Type 2 diabetes in children is rising rapidly worldwide, and these patients often have obesity and experience faster disease progression than adults. Current treatments for children include lifestyle changes, metformin, liraglutide, or insulin, with bariatric surgery considered in some cases. Experts note that current strategies do not fully address the challenges in this group, and emphasize the need for early, intensive, and long-lasting treatments as well as prevention efforts in at-risk children.
AI summary of the abstract below.
| Journal | Expert Opin Pharmacother, 2021 |
|---|---|
| Citations | 6 |
| Relative citation ratio | 0.42 |
| NIH percentile | 25 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
: The number of individuals under 18 years of age with type 2 diabetes is increasing at an alarming rate worldwide. These patients are often characterized by obesity and they often experience a more rapid disease progression than adults with type 2 diabetes. Thus, focus on prevention and management of complications and comorbidities is imperative. With emphasis on weight loss and optimal glycemic control, treatment includes lifestyle changes and pharmacotherapy, which in this patient group is limited to metformin, liraglutide and insulin. In selected cases, bariatric surgery is indicated.: This perspective article provides an overview of the literature covering pathophysiology, diagnosis, characteristics and treatment of pediatric type 2 diabetes, and outlines the gaps in our knowledge where further research is needed. The paper draws on both mechanistic studies, large scale intervention trials, epidemiological studies and international consensus statements.: Type 2 diabetes in pediatric patients is an increasing health care problem, and the current treatment strategies do not successfully meet the many challenges and obstacles in this patient group. Treatments must be early, intensive, multifaceted and durable. Also, prevention of obesity and type 2 diabetes in at-risk children should be addressed and prioritized on all levels.
Verbatim abstract via PubMed 34420454 ↗